Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
1.4K
Cancer02:18

Cancer

51.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.4K
Cancer Therapies02:49

Cancer Therapies

8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Cancer Therapies02:49

Cancer Therapies

2.4K
2.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.

Oncology and therapy·2024
Same author

Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience.

Scientific reports·2023
Same author

Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.

Oncology and therapy·2023
Same author

BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases.

Journal of chemotherapy (Florence, Italy)·2022
Same author

DOACs in patients with brain cancers: promising but still a long way to go.

Blood advances·2022

Related Experiment Video

Updated: Apr 27, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

11.8K

[Update on anticancer drugs].

Fausto Roila, Enzo Ballatori

    Assistenza Infermieristica E Ricerca : AIR
    |July 9, 2014
    PubMed
    Summary
    This summary is machine-generated.

    This review critically assesses recent anticancer drug clinical trials to distinguish reliable innovations from misleading claims. It offers practical guidelines for navigating fast-evolving oncology research and practice.

    More Related Videos

    Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
    06:00

    Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

    Published on: May 14, 2016

    10.8K
    A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
    10:46

    A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

    Published on: September 13, 2022

    4.1K

    Related Experiment Videos

    Last Updated: Apr 27, 2026

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
    15:04

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

    Published on: January 19, 2019

    11.8K
    Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
    06:00

    Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

    Published on: May 14, 2016

    10.8K
    A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
    10:46

    A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

    Published on: September 13, 2022

    4.1K

    Area of Science:

    • Oncology
    • Clinical Pharmacology
    • Evidence-Based Medicine

    Background:

    • The field of oncology is rapidly advancing with new anticancer drugs.
    • Distinguishing between genuinely effective treatments and those lacking robust evidence is crucial for patient care.
    • Research methodologies in oncology trials can be complex and lead to varied interpretations.

    Purpose of the Study:

    • To critically review clinical trials of anticancer drugs published in the last two years.
    • To identify truly innovative and reliable treatments for oncological conditions.
    • To provide methodological guidelines for evaluating cancer research and practice.

    Main Methods:

    • Comprehensive review of clinical trials from major medical and oncological journals.
    • Analysis focused on the last two years of published research.
    • Evaluation of evidence reliability and clinical applicability.

    Main Results:

    • Identification of specific anticancer drugs with documented efficacy and those with questionable or misleading data.
    • Analysis of methodological strengths and weaknesses in recent oncology clinical trials.
    • Highlighting areas of controversy in cancer drug research and clinical application.

    Conclusions:

    • Adoption of evidence-based anticancer drugs requires careful evaluation of trial data.
    • Standardized methodological approaches are needed to ensure reliable oncology research.
    • This review provides a framework for clinicians and researchers to navigate the evolving landscape of cancer therapeutics.